Rx/Reimbursement Adult Incontinence in Austria

  • ID: 4517577
  • Report
  • Region: Austria
  • 14 pages
  • Euromonitor International
1 of 3
Incontinence products are available on prescription in Austria for those who have severe incontinence problems which have been diagnosed by a doctor. This is why the majority of adult incontinence products sold in Austria actually fall under Rx/reimbursement adult incontinence.

The publisher's Rx/Reimbursement adult incontinence in Austria report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2013-2017, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2022 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Rx/Reimbursement adult incontinence market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
2 of 3
RX/REIMBURSEMENT ADULT INCONTINENCE IN AUSTRIA

Headlines

Prospects

Easy Access To Adult Incontinence Products on Prescription
Rx/reimbursement Adult Incontinence Has Less Growth Potential Than Retail Adult Incontinence
High Concentration Expected To Prevail

Category Data
Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2012-2017
Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2012-2017
Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2017-2022
Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2017-2022
Executive Summary
A Good Year for Tissue and Hygiene, Despite Maturity
Private Label Plays A Strong Role, As Price Is A Major Selling Point
Essity Leads Tissue and Hygiene With A Broad Portfolio of Popular Brands
Grocery Retailers Remains the Leading Distribution Channel
Growing Demand Will Not Necessarily Translate Into Equivalent Value Growth
Market Indicators
Table 5 Birth Rates 2012-2017
Table 6 Infant Population 2012-2017
Table 7 Female Population by Age 2012-2017
Table 8 Total Population by Age 2012-2017
Table 9 Households 2012-2017
Table 10 Forecast Infant Population 2017-2022
Table 11 Forecast Female Population by Age 2017-2022
Table 12 Forecast Total Population by Age 2017-2022
Table 13 Forecast Households 2017-2022

Market Data
Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2012-2017
Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2012-2017
Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2013-2017
Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2014-2017
Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2012-2017
Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2012-2017
Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2017
Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2017-2022
Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2017-2022
Sources
Summary 1 Research Sources
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll